EUVIMEDDécouvrir EUVIMED
Crossref

Statin Use and Reduced Risk of Sudden Sensorineural Hearing Loss in Type 2 Diabetes

Tse-Hsi Li, Jr-Shiang Shiu, Wan-Ming Chen, Ben-Chang Shia, Szu-Yuan Wu, Hsuan-Chih Lin

Otolaryngology–Head and Neck Surgery · 2025

DOI: 10.1002/ohn.1214 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2025. Written by Tse-Hsi Li and 5 co-authors. Institution: Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan. Major MEDLINE topics: Diabetes Mellitus, Type 2, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hearing Loss, Sensorineural, Hearing Loss, Sudden. Cited 1 times so far (Crossref); 50 references.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Objective

To examine the association between statin use and the risk of sudden sensorineural hearing loss (SSNHL) in patients with type 2 diabetes (T2D), focusing on statin type, dosage, and treatment duration. Study Design Retrospective cohort study.

Setting

Taiwan National Health Insurance Research Database.

Methods

We analyzed T2D patients diagnosed between 2008 and 2019, stratified into statin users and nonusers of lipid‐lowering therapy. Propensity score matching was used to balance baseline characteristics. Multivariable Cox regression, adjusted for competing risks, assessed the association between statin use and SSNHL risk, as well as all‐cause mortality. Statin exposure was analyzed based on cumulative and daily doses.

Results

The study cohort included 66,120 statin users and 66,120 nonusers. Statin use was associated with a significantly lower SSNHL risk (adjusted hazard ratio [aHR], 0.83; 95% CI, 0.74‐0.92; P = .0008) and reduced all‐cause mortality (aHR, 0.55; 95% CI, 0.52‐0.57; P < .0001). A dose‐response relationship was observed, with higher cumulative defined daily doses (cDDDs) linked to progressively lower SSNHL risk. Hydrophilic statins, particularly rosuvastatin, showed stronger protective effects compared to lipophilic statins.

Conclusion

Statin use in T2D patients is associated with reduced SSNHL risk and all‐cause mortality, with dose‐dependent effects. These findings suggest the potential otoprotective benefits of statins and emphasize the importance of personalized therapy for managing both hearing and cardiovascular health in this high‐risk population.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Hydroxymethylglutaryl-CoA Reductase InhibitorsHearing Loss, SensorineuralHearing Loss, SuddenHumansMaleFemaleRetrospective StudiesMiddle AgedTaiwanAgedRisk Factors

Author keywords

nationwide cohort studypropensity score matchingstatinssudden sensorineural hearing losstype 2 diabetes

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Authors and institutions

  • Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan.
  • Department of Emergency Medicine, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan.
  • Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan.
  • Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan.
  • Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan.
  • Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan.

Cite

APA

Li, T. H., Shiu, J. S., Chen, W. M., Shia, B. C., Wu, S. Y., & Lin, H. C. (2025). Statin Use and Reduced Risk of Sudden Sensorineural Hearing Loss in Type 2 Diabetes. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1214

Vancouver

Li TH, Shiu JS, Chen WM, Shia BC, Wu SY, Lin HC. Statin Use and Reduced Risk of Sudden Sensorineural Hearing Loss in Type 2 Diabetes. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1214

BibTeX
@article{Li2025,
  author = {Li, Tse-Hsi and Shiu, Jr-Shiang and Chen, Wan-Ming and Shia, Ben-Chang and Wu, Szu-Yuan and Lin, Hsuan-Chih},
  title = {Statin Use and Reduced Risk of Sudden Sensorineural Hearing Loss in Type 2 Diabetes},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  doi = {10.1002/ohn.1214}
}
Start for free →